BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 27226234)

  • 1. Tuberous sclerosis complex.
    Henske EP; Jóźwiak S; Kingswood JC; Sampson JR; Thiele EA
    Nat Rev Dis Primers; 2016 May; 2():16035. PubMed ID: 27226234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberous sclerosis complex: A review].
    Pfirmann P; Combe C; Rigothier C
    Rev Med Interne; 2021 Oct; 42(10):714-721. PubMed ID: 33836894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberous sclerosis complex.
    Islam MP; Roach ES
    Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement.
    von Ranke FM; Zanetti G; e Silva JL; Araujo Neto CA; Godoy MC; Souza CA; Mançano AD; Souza AS; Escuissato DL; Hochhegger B; Marchiori E
    Lung; 2015 Oct; 193(5):619-27. PubMed ID: 26104489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
    Lam HC; Siroky BJ; Henske EP
    Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.
    Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL
    Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberous sclerosis: a review of the past, present, and future.
    Uysal SP; Şahin M
    Turk J Med Sci; 2020 Nov; 50(SI-2):1665-1676. PubMed ID: 32222129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition.
    Budde K; Gaedeke J
    Am J Kidney Dis; 2012 Feb; 59(2):276-83. PubMed ID: 22130643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex.
    Franz DN
    Biologics; 2013; 7():211-21. PubMed ID: 24143074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A; Henske EP
    Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.
    Jóźwiak S; Kwiatkowski D; Kotulska K; Larysz-Brysz M; Lewin-Kowalik J; Grajkowska W; Roszkowski M
    J Child Neurol; 2004 Feb; 19(2):102-6. PubMed ID: 15072102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
    MacKeigan JP; Krueger DA
    Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous sclerosis.
    Curatolo P; Maria BL
    Handb Clin Neurol; 2013; 111():323-31. PubMed ID: 23622183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND).
    Gipson TT; Johnston MV
    F1000Res; 2017; 6():. PubMed ID: 28663780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological and neuropsychiatric aspects of tuberous sclerosis complex.
    Curatolo P; Moavero R; de Vries PJ
    Lancet Neurol; 2015 Jul; 14(7):733-45. PubMed ID: 26067126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberous sclerosis complex.
    Hasbani DM; Crino PB
    Handb Clin Neurol; 2018; 148():813-822. PubMed ID: 29478616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberous sclerosis and epilepsy.
    Petrova LD
    Am J Electroneurodiagnostic Technol; 2011 Mar; 51(1):5-15. PubMed ID: 21516926
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.